Pazenir - supply shortage
Resolved
paclitaxel
ShortageHuman
Shortage information
The shortage affecting Pazenir has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Key facts
- Medicines affected
- Pazenir
- Supply shortage status
- Resolved
- International non-proprietary name (INN) or common name
- paclitaxel
- Therapeutic area (MESH)
- Breast Neoplasms
- Pharmaceutical forms affected
- Powder for dispersion for infusion
- Strengths affected
- 5 mg/ml
Key dates
- First published
- Last updated